Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine

The effect of intranasal vaccination of piglets with live non-AR-pathogenic Bordetella bronchiseptica (BB-) against Atrophic Rhinitis (AR) was investigated in a preliminary investigation and in a field trial. In the preliminary investigation 2-day-old SPF piglets (n = 13) were vaccinated. Three weeks after vaccination, challenges were carried out by means of a spray with an AR-pathogenic B (BB+) or an AR-pathogenic Pasteurella multocida (PM+) broth-culture. Four weeks later the piglets were necropsied and examined for atrophy of the ventral conchae (AVC). In contrast with the non-vaccinated SPF piglets, the vaccinated piglets showed a strong and significant reduction of AVC, after both BB+ and PM+ challenge. In the field trial three groups were formed by drawing lots: ten litters (82 piglets) were vaccinated; ten litters (92 piglets) formed the control group and 11 litters (104 piglets) were treated with a placebo. The litters were spread over two units. In unit 1 AR and PM+ were demonstrated incidentally, in unit 2, however, persistently. BB+ was isolated equally frequently in both units. Clinical and bacteriological examinations were done in piglets of 3, 6 and 8 weeks of age. Necropsy examinations was carried out in 41 piglets of 8 weeks of age, chosen randomly by drawing lots. In spite of a second vaccination at the age of 3 weeks, BB- was not well established; this was possibly caused by maternal BB antibodies. In the control and placebo groups PM+ was isolated earlier and more frequently than BB+. It appeared that AVC was correlated more strongly with PM+ than with BB+ infection in the field trial. The percentage of piglets with Brachygnathia superior (BS) at the age of 8 weeks indicated the AR situation in the herd. Although a significant reduction of AVC was determined in unit 2, it was not sufficient to indicate that this method of intranasal vaccination is useful in the prevention of AR in practice.     

Therapeutic efficacy of doxycycline hyclate in experimental Escherichia coli infection in broilers

Treatment of experimentally induced colibacillosis in broilers with doxycycline hyclate through the drinking water was just effective at a dose of 200 mg/kg body weight (1000 ppm). The achieved therapeutic effects were similar to those of tetracycline at the same dose and of flumequine at a dose of 19 mg/kg body weight (100 ppm).     

Comparison of the sensitivity of in vitro and in vivo tests for detection of the presence of a bovine viral diarrhoea virus type 1 strain

Veterinary vaccines are usually tested for the absence of contaminants. However, the quality control does not always imply that vaccines are not contaminated as, for example, illustrated by the bovine herpes virus 1 (BHV1) vaccine used in The Netherlands in 1999 that contained a small amount of bovine viral diarrhoea virus (BVDV1). Thousands of cows were vaccinated with BHV1 vaccine batches, and the question arose as to whether these small amounts of BVDV1, most likely not detected with in vitro tests, could have infected cattle. More in general, the question was whether the outcome of the in vitro tests, i.e. the in vitro infectivity, was indicative for the infectivity for cattle, i.e. the in vivo infectivity. We therefore carried out in vitro experiments to determine the sensitivity of a BVDV1 isolation assay. In addition, we performed two animal experiments, in which we estimated the lowest dose needed to infect calves with BVDV1. We extrapolated the experimental in vitro and in vivo results from a tissue culture infectious dose (TCID50) to a cattle infectious dose (CID50). We observed a partial response in the calves inoculated with this dose: four out of six calves turned out to be infected. In the tissue culture test, all 20 samples tested negative. The response in vivo, however, was not significantly higher than the in vitro response, which implies that no difference in susceptibility was observed between the animal test and the tissue culture test. Based on the results in our experiments, some cattle may have been infected with BVDV1 after the application of the contaminated BHV1 vaccine during the vaccination campaign. The question remains that how many cattle received contaminated vaccine, and became infected with BVDV1.     

Isolation and characterization of a new compound from Prunus mume fruit that inhibits cancer cells

An active compound that inhibits cancer cells was isolated from the fruit of Prunus mume, and its structure and in vitro activities were characterized. The n-hexane fraction obtained from methanol extracts exhibited the strongest inhibitory effect on the growth of cancer cells. From the n-hexane fraction, a new compound named B-1 was purified through preparative thin-layer chromatography, ODS column chromatography, and reverse phase high-performance liquid chromatography and its structure was analyzed by fast atom bombardment mass spectrometry and 1H and 13C NMR. The molecular formula of B-1 was C19H22O6 {2-hydroxy-1-[(7-hydroxy-2-oxo-2H-chromen-6-yl)methyl]-2-methylpropyl-(2Z)-3-methyl-but-e-enoate:prunate}, and the IC50 value was in the range of 39-58 microg/mL in descending order of the cancer cell lines Hep-2, SW-156, HEC-1-B, and SK-OV-3. B-1 exhibited 81-96% inhibition at a concentration level of 100 microg/mL against all cells, based on an 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. However, B-1 showed little effect against normal cells with only 23% or less growth inhibition at 100 microg/mL. Thus, B-1 has a highly specific inhibitory effect against cancer cells but little effect against normal cells. When the cancer cell lines Hep-2 and SK-OV-3 were incubated with B-1 for 72 h, most of the tested cells suffered strong growth inhibition. The compound has the potential to be developed as a nutraceutical.     

The Impact of Migration on Social Capital: Do Migrants Take Their Bowling Balls with Them?

Questions surrounding the impact of population migration on social capital is the focus of this study. Putnam observed that “for people as for plants, frequent repotting disrupts root systems. It takes time for a mobile individual to put down new roots.” However, because of a trending decrease in mobility over time, Putnam rules out migration as an explanation for the long‐term decline in social capital that was the subject of his widely read 1995 book Bowling Alone: America's Declining Social Capital. This study undertakes an empirical examination of the impact of migration on county‐level social capital, which in tribute to Putnam one might view as an attempt to answer the question—do migrants take their bowling balls with them when they move? The potential for county‐level migration of population to impact social capital levels at particular locations in space arises from the conventional argument that social capital promotes trust and cooperation among agents. This trust increases socially efficient collective action but requires investment in relationships and commitment of scarce resources to build social capital. It seems plausible that migration of population might have a negative impact on the stock of social capital by interfering with trust and cooperation among agents. However, it is also possible that migrants may take their social capital with them to new places of residence. In other words, the propensity to join social and civic organizations might reflect inherent traits of individuals who are willing to make commitments of their resources to building social capital in any community where they reside.     

高剂量辐照对鸡肉脯主要营养成分的影响

为研究高剂量辐照灭菌处理对宠物食品主要营养成分的影响,以鸡肉脯为材料,研究了4 kGy、6 kGy、8 kGy、10 kGy、15 kGy、20 kGy、50 kGy、100 kGy和200 kGy的60Coγ射线对其脂肪、蛋白质等营养成分含量的影响。结果表明:鸡肉脯经4～200 kGy辐照后,与对照相比,鸡肉脯中的脂肪含量差异比较明显,但与辐照剂量没有显著的线性相关性,且辐照后脂肪含量最高的(8 kGy)比对照中的含量高2.8%,最低的(20 kGy和100 kGy)比对照中的低5.6%;辐照后鸡肉脯中的蛋白质含量都高于对照,当辐照剂量达到8 kGy时蛋白质含量都显著高于对照中的含量;碳水化合物低于对照;粗纤维、17种氨基酸、微量元素(钙、铁、锰、镁、钠)等与对照无显著差异;锌、钾、磷的含量仅15 kGy、6 kGy和20 kGy处理与对照中的含量有显著差异;与对照相比,经50 kGy以下剂量辐照处理后,鸡肉脯的色泽、风味与滋味、口感无明显变化,可接受性程度好,当剂量达到100～200 kGy时颜色轻微变浅,呈棕色或棕褐色,但不影响品质,风味与滋味没有明显变化,可接受性程度良好。     

Antiviral activity of Alpinia katsumadai extracts against rotaviruses

In vitro anti-rotavirus activity of Alpinia katsumadai (AK) extracts were evaluated against bovine G8P[7] and porcine G5P[7] rotaviruses in two different assay strategies, a mixed treatment assay and a post treatment assay. In the mixed treatment assay, six AK extracts [AK-1 (EtOH extract), AK-3 (H(2)O layer), AK-5 (40% methanol fraction), and AK-9-11 (H(2)O extract, polysaccharide fraction, supernatant fraction)] exhibited inhibitory activities against G5P[7] rotavirus with the EC(50) values ranging from 0.7±0.4 to 33.7±6.5 μg/mL. Extracts AK-1, AK-3, and AK-5 inhibited rotavirus infection against G8P[7] rotavirus, the with EC(50) values of 8.4±2.2 μg/mL, 6.5±0.8 μg/mL and 8.4±5.0 μg/mL, respectively. By hemagglutination inhibition (HI) assay, six AK extracts completely inhibited viral adsorption onto human RBCs in both strains of rotaviruses at less than 11 μg/mL. However, in the post treatment assay, there was no anti activity shown against both strains of rotaviruses. As a result, six AK extracts were attributed mainly to having a strong interaction with hemagglutinin protein on the outer surface of rotavirus, resulting to blockage of viral adsorption.